Lilly Strikes Deal for Orna Therapeutics for Up to $2.4 Billion
Eli Lilly & Co agreed to buy US biotech Orna Therapeutics Inc. for up $2.4 billion in cash in the…
Eli Lilly & Co agreed to buy US biotech Orna Therapeutics Inc. for up $2.4 billion in cash in the…
Eli Lilly & Co. is paying $350 million upfront to collaborate with Chinese biotech Innovent Biologics Inc. in developing new…
Eli Lilly ‘s fourth-quarter results blew past Wall Street estimates on Wednesday, as key GLP-1 drugs, Mounjaro for diabetes and…
Source: Bloomberg, 2:46 www.bloomberg.com #Stock #Movers #AMD #Super #Micro #Computer #Eli #Lilly #Podcast
Source: Bloomberg, 4:41 www.bloomberg.com #Stock #Movers #Silicon #Lab #Eli #Lilly #Chipotle #Podcast
Late last year, Lilly was the first pharmaceutical stock to reach a $1 trillion valuation. www.marketwatch.com #Lilly #Mounjaro #Zepbound #sales…
Source: Bloomberg, 4:33 www.bloomberg.com #Stock #Movers #Uber #Eli #Lilly #Chipotle #Podcast
Eli Lilly & Co. provided an upbeat sales forecast for the year Wednesday as strong demand for its weight loss…
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik Tavitian |…
The stock market is well-positioned to bounce next week if the heavyweight companies set to report earnings deliver strong numbers,…